FDA Inspection 1291770 — Gideon Hirschfield, M.D.
The FDA completed an inspection of Gideon Hirschfield, M.D. on Nov 7, 2025 in Toronto. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Toronto (Canada)
Additional Details
Clinical Investigator (CI)